Nymirum was the first company launched to target RNA with small molecules and was founded by the pioneers of this space. We have built a robust platform specifically to address the unique challenges of targeting RNA and to lead the advancement of the industry into the next frontier of drug development

We have successfully partnered with some of the largest pharmaceutical companies in the world to accelerate their RNA drug discovery.


Our current areas of interest:

Reach out to us


Chicago, IL 60611

Durham, NC 27713

© 2020 by Nymirum Inc. All rights reserved.